Seftazidim: Perbedaan antara revisi
Konten dihapus Konten ditambahkan
Tidak ada ringkasan suntingan Tag: Suntingan perangkat seluler Suntingan peramban seluler Suntingan seluler lanjutan |
Tidak ada ringkasan suntingan Tag: Suntingan perangkat seluler Suntingan peramban seluler Suntingan seluler lanjutan |
||
Baris 9:
| alt2 = <!-- Clinical data -->
| pronounce = {{IPAc-en|s|ɛ|f|ˈ|t|æ|z|ᵻ|d|iː|m}}<br />{{respell|sef|TAZ|i|deem}}
| tradename = Fortaz, Tazicef,
| Drugs.com = {{drugs.com|monograph|ceftazidime}}
| MedlinePlus = a686007
Baris 17:
| pregnancy_AU_comment =
| pregnancy_category =
| routes_of_administration = [[
| class = [[Third-generation cephalosporin]]
| ATCvet =
Baris 43:
| legal_status = <!-- For countries not listed above -->
<!-- Pharmacokinetic data -->| bioavailability = 91% ([[
| protein_bound =
| metabolism =
| metabolites =
| onset =
| elimination_half-life = 1
| duration_of_action =
| excretion = 90–96% [[
<!-- Identifiers -->| CAS_number_Ref = {{cascite|correct|??}}
Baris 71:
| PDB_ligand =
| synonyms = <!-- Chemical and physical data -->
| IUPAC_name = (6''R'',7''R'',''Z'')-7-(2-(2-
| C = 22
| H = 22
| |||